CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-27 | MILLIGAN DAVID V Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2019-03-07 | Taub Rebecca Chief Medical Officer, EVP R&D | Grant or award · Stock Option (Right to Buy) | +38,000 | 38,000 | ||
| 2019-03-07 | FRIEDMAN PAUL A Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2019-03-07 | Schneebaum Marc R Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +28,000 | 28,000 | ||
| 2018-11-21 | MILLIGAN DAVID V Director | Sale | −20,000 | $112.54 | $2.3M | 0 |
| 2018-11-20 | FRIEDMAN PAUL A Chief Executive Officer | Purchase | +4,000 | $117.88 | $472K | 161,128 |
| 2018-11-19 | MILLIGAN DAVID V Director | Sale | −10,000 | $131.60 | $1.3M | 20,000 |
| 2018-11-19 | FRIEDMAN PAUL A Chief Executive Officer | Purchase | +4,000 | $124.00 | $496K | 157,128 |
| 2018-11-19 | CRAVES FRED B Director | Purchase | +100 | $123.17 | $12K | 296,167 |
| 2018-11-19 | CRAVES FRED B Director | Purchase | +1,000 | $124.57 | $125K | 297,167 |
| 2018-11-19 | CRAVES FRED B Director | Purchase | +900 | $125.00 | $113K | 298,067 |
| 2018-11-14 | MILLIGAN DAVID V Director | Option exercise | +10,000 | $16.46 | $165K | 30,000 |
| 2018-11-14 | MILLIGAN DAVID V Director | Option exercise · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2018-09-18 | MILLIGAN DAVID V Director | Option exercise | +20,000 | $9.45 | $189K | 20,000 |
| 2018-09-18 | MILLIGAN DAVID V Director | Option exercise · Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2018-06-19 | BATE KENNETH Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2018-06-19 | Levy Richard S Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2018-06-19 | MILLIGAN DAVID V Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2018-06-19 | Gollust Keith R Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2018-06-19 | CRAVES FRED B Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 |
Page 55 of 82 · 1,629 trades